This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barrette, R. W.
Right arrow Articles by Silbart, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barrette, R. W.
Right arrow Articles by Silbart, L. K.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, July 2006, p. 802-805, Vol. 13, No. 7
1071-412X/06/$08.00+0     doi:10.1128/CVI.00422-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Quantifying Specific Antibody Concentrations by Enzyme-Linked Immunosorbent Assay Using Slope Correction

Roger W. Barrette, Jessica Urbonas,{dagger} and Lawrence K. Silbart*

Center of Excellence for Vaccine Research, Department of Animal Science, CANR, 1390 Storrs Road, ABL Room 302E, Unit 4163, University of Connecticut, Storrs, Connecticut 06269-4163

Received 23 December 2005/ Returned for modification 27 February 2006/ Accepted 8 May 2006

Assessing the magnitude of an antibody response is important to many research and clinical endeavors; however, there are considerable differences in the experimental approaches used to achieve this end. Although the time-honored approach of end point titration has merit, the titer can often be misleading due to differences in how it is calculated or when samples contain high concentrations of low-avidity antibodies. One frequently employed alternative is to adapt commercially available enzyme-linked immunosorbent assay kits, designed to measure total antibody concentrations, to estimate antigen-specific antibody concentrations. This is accomplished by coating the specific antigen of interest in place of the capture antibody provided with the kit and then using the kit's standard curve to quantify the specific antibody concentration. This approach introduces considerable imprecision, due primarily to its reliance on a single sample dilution. This "single-point" approach fails to address differences in the slope of the sample titration curve compared to that of the standard curve. Here, we describe a general approach for estimating the effective concentration of specific antibodies, using antisera against foot-and-mouth disease virus VP1 peptide. This was accomplished by initially calculating the slope of the sample titration curve and then mathematically correcting the slope to that of a corresponding standard curve. A significantly higher degree of precision was attained using this approach rather than the single-point method.

* Corresponding author. Mailing address: University of Connecticut, Center of Excellence for Vaccine Research, 1390 Storrs Rd., ABL Room 302E, Unit 4163, Storrs, CT 06269-4163. Phone: (860) 486-6073. Fax: (860) 486-5067. E-mail: Lawrence.Silbart{at}uconn.edu.

{dagger} Present address: Cornell University School of Veterinary Medicine, Ithaca, N.Y.

Clinical and Vaccine Immunology, July 2006, p. 802-805, Vol. 13, No. 7
1071-412X/06/$08.00+0     doi:10.1128/CVI.00422-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»